Skip to main content
. 2015 Jan 23;9:273–282. doi: 10.2147/DDDT.S66654

Figure 8.

Figure 8

Vildagliptin-content plot for the gelatin vildagliptin nanoparticles (GVN) formulation (real-time storage conditions).

Note: Percentage of label claim refers to drug content.